Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0000930413-08-000589

Head of Technical Affairs bought 9,000 shares at an average $1.16 ($10,400)

From the SEC's structured data for this filing

Trades in this filing

BEHL CHARAN · Head of Technical Affairs

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2008-01-28 Purchase : show line 1 in the form +4,000 $1.15 $4,600 425,000 D
2008-01-25 Purchase : show line 2 in the form +5,000 $1.16 $5,800 421,000 D
Open-market purchases · 9,000 sh · avg $1.16 · $10,400
Loading xslF345X02/c52146_ex.xml…